Search
AI-Driven Drug Discovery Poised for Breakthrough, as Capital Titans Scramble to Secure Their Stake
3 day ago /
Read about 0 minute
Author：小编
In early July, the esteemed AI enterprise Anthropic introduced Claude Science, an AI solution crafted specifically for scientists and pharmaceutical firms, and simultaneously launched its own independent drug discovery project. Not long after, Insilico Medicine, a Chinese AI-driven drug discovery company, forged a global strategic partnership with Takeda, a Japanese pharmaceutical powerhouse, in a deal valued at up to US$600 million. These milestones signal that AI-driven drug discovery is on the cusp of a new era, evolving from a theoretical concept in labs to a high-tech industry with real-world value. In this arena, the distinctive strengths of Chinese companies are steadily rising to prominence.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
